{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:59:14Z","timestamp":1790506754440,"version":"4.1.0"},"reference-count":46,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2008,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant characteristics, <jats:italic>e.g<\/jats:italic>., fertility rate, age\u2010of\u2010mother at first birth and a national screening programme for several years. The aim of this study is to compare trends in incidence of and mortality from cervical cancer in Finland and the Netherlands in relation to the introduction and intensity of the screening programmes. Therefore, incidence and mortality rates were calculated using the Cancer Registries of Finland and the Netherlands. Data on screening intensity were obtained from the Finnish Cancer Registry and the Dutch evaluation centre at ErasmusMC\u2010Rotterdam. Women aged 30\u201360 have been screened every 5 years, in Finland since 1992 and in the Netherlands since 1996. Screening protocols for smear taking and referral to the gynaecologist are comparable. Incidence and mortality rates have declined more in Finland. In 2003, age\u2010adjusted incidence and mortality in Finland were 4.0 and 0.9 and in the Netherlands 4.9 and 1.4 per 100,000 woman\u2010years, respectively. Excess smear use in the Netherlands was estimated to be 24 per 1,000 women during a 5\u2010year interval compared to 121 in Finland. The decline in mortality in Finland seems to be almost completely related to the screening programme whereas in the Netherlands it was initially considered to be a natural decline. Differences in risk factors might also play a role: the Netherlands has higher population density and higher percentages of immigrants and (female) smokers. The greater excess smear use in Finland might also have affected incidence. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.23276","type":"journal-article","created":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T18:47:33Z","timestamp":1197053253000},"page":"1854-1858","source":"Crossref","is-referenced-by-count":73,"title":["Mass screening programmes and trends in cervical cancer in Finland and the Netherlands"],"prefix":"10.1002","volume":"122","author":[{"given":"Maaike A.","family":"van der Aa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018435522475"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00330-0"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602069"},{"key":"e_1_2_6_5_2","volume-title":"Handbook of cancer prevention","author":"International Agency for Research on Cancer","year":"2005"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112253"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16674-9"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7113.953"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11530"},{"key":"e_1_2_6_10_2","first-page":"1380","article-title":"Vaccination against human papillomavirus for the prevention of cervical cancer","volume":"150","author":"Quint WG","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21513"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.031690"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603575"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.122"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-6-252"},{"key":"e_1_2_6_16_2","first-page":"309","article-title":"Social differences in sexual behaviour and cervical cancer","author":"de Sanjose S","year":"1997","journal-title":"IARC Sci Publ"},{"key":"e_1_2_6_17_2","first-page":"1017","article-title":"Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection","volume":"164","author":"Franco EL","year":"2001","journal-title":"CMAJ"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00346-4"},{"key":"e_1_2_6_19_2","unstructured":"WHO\u2014European health. Available at:http:\/\/www.euro.who.int\/hfadb.2006."},{"key":"e_1_2_6_20_2","unstructured":"United Nations Economic Commission for Europe: Statistical Database. Available at:http:\/\/www.unece.org\/stats\/data.htm.2007."},{"key":"e_1_2_6_21_2","volume-title":"Incidence of cancer in the Netherlands 1998","author":"Visser O","year":"2002"},{"key":"e_1_2_6_22_2","unstructured":"Statistics Netherlands (CBS). Available at:http:\/\/statline.cbs.nl\/StatWeb.2005."},{"key":"e_1_2_6_23_2","unstructured":"Finnish Cancer Registry. Available at:http:\/\/www.cancerregistry.fi\/atlasweb\/index.htm.2007."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00311-7"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(88)90045-5"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601157"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(00)00317-8"},{"key":"e_1_2_6_28_2","unstructured":"PapanicolaouGN. New cancer diagnosis. Proceedings of Third Race Betterment Conference. Michigan USA1928.528\u201334."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22167"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450305"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20678"},{"key":"e_1_2_6_33_2","first-page":"403","article-title":"A screening programme for cervical cancer that worked","volume":"7","author":"Hakama M","year":"1988","journal-title":"Cancer Surv"},{"issue":"9","key":"e_1_2_6_34_2","first-page":"1","article-title":"Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017","volume":"36","author":"Hristova L","year":"1997","journal-title":"Acta Oncol"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.01.048"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/17.2.270"},{"key":"e_1_2_6_38_2","unstructured":"International Agency for Research on Cancer Globocan. Available at:http:\/\/www\u2010dep.iarc.fr\/.2007."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.12.010"},{"key":"e_1_2_6_40_2","volume-title":"Kanker van KWF Kankerbestrijding. Allochtonen en kanker","author":"Signaleringscommissie","year":"2006"},{"key":"e_1_2_6_41_2","unstructured":"Comprehensive Cancer Centres. Available at:http:\/\/www.ikcnet.nl\/.2007."},{"key":"e_1_2_6_42_2","unstructured":"Eurosurveillance. Available at:http:\/\/www.eurosurveillance.org.2007."},{"key":"e_1_2_6_43_2","unstructured":"European Medicines Agency. Available at:http:\/\/emea.europa.eu.2007."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601763"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2001.00119.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.99023.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90615-Z"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.23276","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.23276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:41:12Z","timestamp":1697182872000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.23276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,4,15]]}},"alternative-id":["10.1002\/ijc.23276"],"URL":"https:\/\/doi.org\/10.1002\/ijc.23276","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}